Skip to main content
Premium Trial:

Request an Annual Quote

Microfluidics Firm Dolomite Licenses IP from Japan Science and Technology Agency

Premium

Microfluidics firm Dolomite said this week that it has licensed microdroplet generation technology from the Japan Science and Technology Agency.

Under the agreement, Royston, UK-based Dolomite has a license to JST's microdroplet generation patent families including WO 2002/068104, entitled "Process for producing emulsion and microcapsules and apparatus therefor;" and WO 2005/089921, "Method and device for producing micro-droplets."

Dolomite said that the license authorizes it to grant sub-licenses to the technology, and that its customers may now purchase and freely use Dolomite droplet chips for R&D purposes.

The company offers a wide range of droplet-forming devices featuring different junction geometries, channel sizes, and surface properties for use in applications such as compartmentalized chemistry, single-cell analysis, high-throughput screening, droplet PCR, and emulsion studies.

Earlier this year, Dolomite announced a collaboration with San Francisco-based startup GigaGen to develop droplet merger chips for GigaGen's Cell-Seq platform for massively parallel single-cell genetic analyses using highly multiplexed PCR and next-generation sequencing (PCR Insider, 2/23/2012).

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.